LONARDI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.671
AS - Asia 374
EU - Europa 248
SA - Sud America 5
Totale 3.298
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.667
CN - Cina 226
SG - Singapore 134
IT - Italia 75
DE - Germania 47
FI - Finlandia 34
FR - Francia 25
GB - Regno Unito 24
SE - Svezia 20
UA - Ucraina 11
IN - India 6
CA - Canada 4
NL - Olanda 4
BR - Brasile 2
CL - Cile 2
ES - Italia 2
IE - Irlanda 2
IR - Iran 2
TR - Turchia 2
AR - Argentina 1
BE - Belgio 1
BG - Bulgaria 1
HK - Hong Kong 1
LV - Lettonia 1
MK - Macedonia 1
PH - Filippine 1
PK - Pakistan 1
SY - Repubblica araba siriana 1
Totale 3.298
Salva come PNG Salva come JPEG
Città #
Fairfield 463
Chandler 346
Ashburn 199
Seattle 190
Cambridge 174
Woodbridge 174
Houston 167
Ann Arbor 128
Wilmington 125
Singapore 113
Boardman 64
Santa Clara 60
Beijing 55
San Diego 49
Medford 43
Princeton 43
Helsinki 30
Des Moines 27
Padova 27
Guangzhou 20
Roxbury 17
Jacksonville 12
Los Angeles 11
Munich 8
Nanjing 8
New York 8
London 7
Nanchang 7
Changsha 6
Hefei 6
Jinan 6
Dallas 5
Falls Church 5
Shenyang 5
Alassio 4
Hebei 4
Kharkiv 4
Kilburn 4
Kunming 4
Moscow 4
Ningbo 4
Shanghai 4
Milan 3
New Bedfont 3
Ogden 3
Prescot 3
Pune 3
Taizhou 3
Tappahannock 3
Zhengzhou 3
Ankara 2
Chengdu 2
Chicago 2
Chongqing 2
Cusano Milanino 2
Dublin 2
Giugliano In Campania 2
Haikou 2
Hangzhou 2
Hanover 2
Jiaxing 2
Lanzhou 2
Lappeenranta 2
Madrid 2
Menlo Park 2
Norwalk 2
Nürnberg 2
Ottawa 2
Santiago 2
Soemmerda 2
Stockholm 2
Tehran 2
Terni 2
Trento 2
Treviso 2
Vicenza 2
Vicopisano 2
Xian 2
Bologna 1
Borås 1
Brussels 1
Cangzhou 1
Castelfranco Veneto 1
Cesena 1
Columbus 1
Dearborn 1
Dolo 1
Elk Grove Village 1
Erding 1
Falkenstein 1
Frankfurt am Main 1
Hounslow 1
Indiana 1
Jose Maria Ezeiza 1
Latham 1
Manila 1
Mardan 1
Modena 1
Monmouth Junction 1
Mumbai 1
Totale 2.742
Salva come PNG Salva come JPEG
Nome #
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 175
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients 145
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 139
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer 132
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer 128
Immunotherapy in Gastrointestinal Cancers 125
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 120
Immunotherapy in Gastrointestinal Cancers 117
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 115
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study 114
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 108
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 108
An untreatable dyspnoea: more defendants under investigation 101
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)–cT3 rectal cancer 101
PD-L1 expression in gastroesophageal dysplastic lesions 97
Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center 84
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer 81
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer? 76
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives 67
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis 66
MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors 66
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 64
Lymph node ratio is a powerful prognostic factor in patients receiving preoperative chemoradiotherapy for rectal cancer. 63
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis 63
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab 62
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial 59
Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM) 57
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes 51
Modulation of preoperative chemoradiation can reduce the requirement for abdomino-perineal resection in low rectal cancer patients 50
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study 50
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer 43
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 39
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 35
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study 34
Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches 33
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 33
Proposta di PDTA per i pazienti affetti da tumore del pancreas 30
Negative Ultraselection of Patients with RAS / BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy 29
Ramucirumab: the long and winding road toward being an option for mCRC treatment 29
BRAF-mutated colorectal adenocarcinomas: pathological heterogeneity and clinical implications 29
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 25
Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter 24
Multimodal treatment of radiation-induced esophageal cancer: Results of a case-matched comparative study from a single center 24
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling 23
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 23
Mismatch repair status and gastro-oesophageal dysplasia: need for a dedicated gastrointestinal pathologist? 23
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 22
Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma 21
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study 16
null 15
HER2-CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients' Survival in HER2-Positive Metastatic Gastric Adenocarcinoma 11
Platinum sensitivity in patients with IDH1/2 mutated versus wild-type intrahepatic cholangiocarcinoma: a propensity score-based study 8
To resect or not to resect?-the dilemma in oligometastatic breast cancer 7
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 3
Totale 3.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.405
article - articoli 16.876
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020491 0 0 0 0 52 41 94 76 85 50 39 54
2020/2021517 23 120 18 34 10 51 17 63 53 70 38 20
2021/2022572 28 64 46 36 32 29 61 42 48 13 43 130
2022/2023614 92 82 11 95 78 68 12 49 77 10 33 7
2023/2024343 11 64 37 21 22 56 44 3 13 14 28 30
2024/2025356 3 117 52 58 126 0 0 0 0 0 0 0
Totale 3.363